A multicenter randomized trial of Fludarabine and Mitoxantrone (FM) plus Rituximab versus CHOP plus Rituximab as first-line treatment in patients with follicular lymphoma (FL).

被引：0
|
作者：
Zinzani, PL [1 ]
机构：
[1] Univ Bologna, Inst Hematol & Med Oncol L & A Seranoli, I-40126 Bologna, Italy
来源：
BLOOD | 2002年 / 100卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
344
引用
收藏
页码：93A / 93A
页数：1
相关论文
共 50 条
  • [1] A randomized trial of fludarabine and mitoxantrone plus rituximab versus CHOP plus rituximab as first-line treatment in patients with follicular lymphoma.
    Zinzani, PL
    BLOOD, 2001, 98 (11) : 842A - 842A
  • [2] Fludarabine plus mitoxantrone with and without rituximab versus CHOP with and without rituximab as front-line treatment for patients with follicular lymphoma
    Zinzani, PL
    Pulsoni, A
    Perrotti, A
    Soverini, S
    Zaja, F
    De Renzo, A
    Storti, S
    Lauta, VM
    Guardigni, L
    Gentilini, P
    Tucci, A
    Molinari, AL
    Gobbi, M
    Falini, B
    Fattori, PP
    Ciccone, F
    Alinari, L
    Martelli, M
    Pileri, S
    Tura, S
    Baccarani, M
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (13) : 2654 - 2661
  • [3] Bendamustine plus Rituximab Versus R-CHOP as First-Line Treatment for Patients with Follicular Lymphoma Grade 3A: Evidence from a Multicenter, Retrospective Study
    Mondello, Patrizia
    Steiner, Normann
    Willenbacher, Wolfgang
    Cerchione, Claudio
    Nappi, Davide
    Mauro, Endri
    Ferrero, Simone
    Cuzzocrea, Salvatore
    Mian, Michael
    ONCOLOGIST, 2018, 23 (04): : 454 - 460
  • [4] RADIOTHERAPY PLUS RITUXIMAB AS FIRST-LINE REGIMEN FOR LOCALIZED FOLLICULAR LYMPHOMA
    Cencini, E.
    Puccini, B.
    Rigacci, L.
    Fabbri, A.
    Kovalchuk, S.
    Mannelli, L.
    Benelli, G.
    Carfagno, T.
    Simontacchi, G.
    Bocchia, M.
    Bosi, A.
    HAEMATOLOGICA, 2017, 102 : 108 - 109
  • [5] Radiotherapy plus rituximab as first-line regimen for localized follicular lymphoma
    Cencini, Emanuele
    Puccini, Benedetta
    Rigacci, Luigi
    Fabbri, Alberto
    Kovalchuk, Sofia
    Mannelli, Lara
    Benelli, Gemma
    Carfagno, Tommaso
    Simontacchi, Gabriele
    Bocchia, Monica
    Bosi, Alberto
    LEUKEMIA & LYMPHOMA, 2018, 59 (06) : 1420 - 1426
  • [6] Fludarabine, cyclophosphamide and rituximab as first-line treatment in patients with newly diagnosed follicular lymphoma
    De la Cruz Vicente, Fatima
    Carrillo-Cruz, Estrella
    Sole Rodriguez, Maria
    Marin Niebla, Ana
    Martino Galiana, Maria Luz
    Falantes Gonzalez, Jose
    Montero Cuadrado, Isabel
    Gonzalez Campos, Jose
    Espigado Tocino, Ildefonso
    Rios-Herranz, Eduardo
    Antonio Perez-Simon, Jose
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2014, 93 (06) : 469 - 475
  • [7] COMPARISON OF FIRST-LINE TREATMENT WITH BENDAMUSTINE PLUS RITUXIMAB VERSUS R-CHOP FOR PATIENTS WITH FOLLICULAR LYMPHOMA GRADE 3A: RESULTS OF AN ITALIAN MULTICENTER, RETROSPECTIVE STUDY
    Margiotta-Casaluci, G.
    Bigliardi, S.
    Cocito, F.
    Meli, E.
    Petrucci, L.
    Nicolosi, M.
    Annibali, O.
    Boccomini, C.
    Bozzola, V.
    Castellino, A.
    Cattina, F.
    Cenfra, N.
    Ciavarella, S.
    Kovalchuk, S.
    Rotondo, F.
    Fama, A.
    Olivieri, J.
    Zaja, F.
    HAEMATOLOGICA, 2021, 106 (10) : 91 - 91
  • [8] Fludarabine/mitoxantrone versus CHOP followed by rituximab consolidation in chemotherapy-naive follicular lymphoma
    不详
    CLINICAL LYMPHOMA, 2003, 4 (01): : 10 - 10
  • [9] Fludarabine, Cyclophosphamide and Rituximab As First Line Treatment In Follicular Lymphoma
    Vicente, Fatima de la Cruz
    Cruz, Estrella Carrillo
    Rodriguez, Maria Sole
    Niebla, Ana Marin
    Herranz, Eduardo Rios
    Galiana, Maria Luz Martino
    Gonzalez, Jose Falantes
    Cuadrado, Isabel Montero
    Campos, Jose Gonzalez
    Tocino, Ildefonso Espigado
    Perez-Simon, Jose A.
    BLOOD, 2013, 122 (21)
  • [10] CVP chemotherapy plus rituximab compared with CVP as first-line treatment for advanced follicular lymphoma
    Marcus, R
    Imrie, K
    Belch, A
    Cunningham, D
    Flores, E
    Catalano, J
    Solal-Celigny, P
    Offner, F
    Walewski, J
    Raposo, J
    Jack, A
    Smith, P
    BLOOD, 2005, 105 (04) : 1417 - 1423
12345